We are live on
!
Find out more
WC
Wexford Capital Portfolio holdings
AUM
$690M
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-5.08%
1 Year Est. Return
+57.92%
3 Year Est. Return
+92.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.35B
AUM Growth
+$118M
(+9.6%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
13.8%
Top 10 Holdings %
Top 10 Hldgs %
65.38%
Holding
218
New
96
Increased
24
Reduced
32
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mammoth Energy Services
TUSK
|
+$85.2M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$39.6M |
| 3 |
Diamondback Energy
FANG
|
+$34.7M |
| 4 |
PE
PARSLEY ENERGY INC
PE
|
+$34.4M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$43.8M |
| 2 |
Kinder Morgan
KMI
|
+$25.2M |
| 3 |
BHI
Baker Hughes
BHI
|
+$22.6M |
| 4 |
JetBlue
JBLU
|
+$17.3M |
| 5 |
Enterprise Products Partners
EPD
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 40.09% |
| 2 | Energy | 25.27% |
| 3 | Consumer Discretionary | 4.88% |
| 4 | Financials | 2.66% |
| 5 | Communication Services | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Alkermes
ALKS
$8.82B
| $365K | 0.03% |
+6,300
| New | +$366K |
|
|
CLVS
127
DELISTED
Clovis Oncology, Inc.
CLVS
| $365K | 0.03% |
+3,900
| New | +$239K |
|
128
Bio-Techne
TECH
$11.2B
| $364K | 0.03% |
+12,400
| New | +$339K |
|
129
Amgen
AMGN
$203B
| $362K | 0.03% |
+2,100
| New | +$342K |
|
130
Vertex Pharmaceuticals
VRTX
$121B
| $361K | 0.03% |
+2,800
| New | +$337K |
|
131
Neurocrine Biosciences
NBIX
$17.7B
| $359K | 0.03% |
+7,800
| New | +$378K |
|
132
Jazz Pharmaceuticals
JAZZ
$15.9B
| $358K | 0.03% |
+2,300
| New | +$352K |
|
133
BioMarin Pharmaceuticals
BMRN
$11.5B
| $354K | 0.03% |
+3,900
| New | +$355K |
|
134
Biogen
BIIB
$29.9B
| $353K | 0.03% |
+1,300
| New | +$344K |
|
|
ALXN
135
DELISTED
Alexion Pharmaceuticals
ALXN
| $353K | 0.03% |
+2,900
| New | +$338K |
|
136
Acadia Pharmaceuticals
ACAD
$4.25B
| $351K | 0.03% |
+12,600
| New | +$376K |
|
|
CELG
137
DELISTED
Celgene Corp
CELG
| $351K | 0.03% |
+2,700
| New | +$331K |
|
|
SAGE
138
DELISTED
Sage Therapeutics
SAGE
| $350K | 0.03% |
+4,400
| New | +$318K |
|
139
Range Resources
RRC
$9.11B
| $348K | 0.03% |
15,000
-3,200
| -18% | -$80.7K |
|
|
BLUE
140
DELISTED
bluebird bio
BLUE
| $347K | 0.03% |
+255
| New | +$308K |
|
141
Illumina
ILMN
$29.4B
| $347K | 0.03% |
+2,056
| New | +$356K |
|
|
SHPG
142
DELISTED
Shire pic
SHPG
| $347K | 0.03% |
+2,100
| New | +$367K |
|
143
Regeneron Pharmaceuticals
REGN
$68.8B
| $344K | 0.03% |
+700
| New | +$306K |
|
144
Alnylam Pharmaceuticals
ALNY
$36.3B
| $343K | 0.03% |
+4,300
| New | +$275K |
|
145
GeoPark
GPRK
$649M
| $341K | 0.03% |
+45,381
| New | +$349K |
|
146
Incyte
INCY
$23.5B
| $340K | 0.03% |
+2,700
| New | +$344K |
|
|
ICPT
147
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $339K | 0.03% |
+2,800
| New | +$324K |
|
148
Park Hotels & Resorts
PK
$2.97B
| $327K | 0.02% |
12,140
-12,500
| -51% | -$330K |
|
149
Peabody Energy
BTU
$2.78B
| $325K | 0.02% |
+13,301
| New | +$329K |
|
150
Qualys
QLYS
$4.84B
| $298K | 0.02% |
+7,300
| New | +$293K |
|
Similar funds
SSA
WIM
LCP
SAM
ACM
PPI
BSSFA
CPA
Wexford Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Wexford Capital held 218 positions worth $1.35B, up 9.6% from $1.23B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Wexford Capital deployed $186M of net new capital in Q2 2017, opening 96 new positions and adding to 24 existing holdings. Its largest new stake was PARSLEY ENERGY INC: 1,155,258 shares worth $32.1M.
By sector, the portfolio is most concentrated in Industrials at 40% of assets, down from 43% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Enterprise Products Partners, an estimated $15.8M trimmed.
- Wexford Capital's largest Q2 2017 buy was PARSLEY ENERGY INC: 1,155,258 shares worth $32.1M.
- Wexford Capital added most to Mammoth Energy Services in Q2 2017, an estimated $85.2M increase.
- Wexford Capital's biggest Q2 2017 reduction was Enterprise Products Partners, cutting an estimated $15.8M.
- Wexford Capital fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $43.8M.
- Wexford Capital's ten largest holdings make up 65% of its $1.35B portfolio in Q2 2017.
- Wexford Capital opened 96 new positions and closed 49 in Q2 2017.
- Wexford Capital's portfolio value rose 9.6% quarter-over-quarter to $1.35B.
Based on Wexford Capital's 13F filing for Q2 2017, filed 11 Aug 2017.